Agilon Health (NYSE:AGL) Stock Rating Upgraded by Zacks Research

Agilon Health (NYSE:AGL) was upgraded by investment analysts at Zacks Research from a “strong sell” rating to a “hold” rating in a research note issued on Tuesday,Zacks.com reports.

Other equities research analysts also recently issued reports about the company. Sanford C. Bernstein reiterated a “market perform” rating and issued a $1.40 price target (down from $4.00) on shares of Agilon Health in a report on Wednesday, August 20th. Weiss Ratings reiterated a “sell (e+)” rating on shares of Agilon Health in a report on Wednesday, October 8th. Wells Fargo & Company reduced their price target on Agilon Health from $5.00 to $1.50 and set an “overweight” rating on the stock in a report on Tuesday, October 7th. Robert W. Baird reduced their price objective on Agilon Health from $5.00 to $1.00 and set a “neutral” rating on the stock in a report on Thursday, August 14th. Finally, Barclays reduced their price objective on Agilon Health from $3.00 to $1.50 and set an “underweight” rating on the stock in a report on Wednesday, August 6th. Four investment analysts have rated the stock with a Buy rating, thirteen have given a Hold rating and two have given a Sell rating to the stock. According to MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $2.81.

Agilon Health Stock Performance

Shares of NYSE AGL opened at $0.94 on Tuesday. The business’s 50 day moving average price is $1.12 and its 200-day moving average price is $2.19. Agilon Health has a fifty-two week low of $0.71 and a fifty-two week high of $6.08. The company has a market cap of $389.14 million, a price-to-earnings ratio of -1.22 and a beta of 0.07.

Agilon Health (NYSE:AGL) last issued its quarterly earnings results on Monday, August 4th. The company reported ($0.25) earnings per share for the quarter, missing the consensus estimate of ($0.11) by ($0.14). Agilon Health had a negative return on equity of 66.76% and a negative net margin of 5.35%.The business had revenue of $1.39 billion during the quarter, compared to analysts’ expectations of $1.47 billion. During the same quarter in the previous year, the company posted ($0.07) earnings per share. The company’s quarterly revenue was down 5.9% compared to the same quarter last year. Sell-side analysts predict that Agilon Health will post -0.59 earnings per share for the current year.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of the company. Simplify Asset Management Inc. boosted its position in Agilon Health by 13.8% during the 3rd quarter. Simplify Asset Management Inc. now owns 113,976 shares of the company’s stock valued at $117,000 after acquiring an additional 13,824 shares in the last quarter. Apollon Wealth Management LLC bought a new stake in Agilon Health during the 3rd quarter valued at $72,000. Inspire Investing LLC boosted its position in Agilon Health by 156.5% during the 3rd quarter. Inspire Investing LLC now owns 427,711 shares of the company’s stock valued at $441,000 after acquiring an additional 260,970 shares in the last quarter. Atwood & Palmer Inc. bought a new stake in Agilon Health during the 3rd quarter valued at $216,000. Finally, State of Wyoming boosted its position in Agilon Health by 31.1% during the 2nd quarter. State of Wyoming now owns 168,461 shares of the company’s stock valued at $387,000 after acquiring an additional 39,952 shares in the last quarter.

Agilon Health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.